申请人:Perez Gonzalez Juan Jesus
公开号:US20080125378A1
公开(公告)日:2008-05-29
The compounds of formula (1), wherein n is an integer from 0 to 4; R1 is a radical selected from the group consisting of H, CH
3
, CH
2
-CH
3
, C(CH
3
)
3
, COOH, CONH
2
and C=CH; R2, R3, R4 and R5 are radicals independently selected from the group consisting of H, F, Cl, Br, (C
1
-C
3
)-alkoxyl and (C
1
-C
4
)-alkyl; and R6 is a radical selected from the group consisting of H, F, Cl, Br, (C
1
-C
3
)-alkoxyl, (C
1
-C
4
)-alkyl, R7, CH=CH-R7 and O-CH
2
-R7; wherein R7 is phenyl or phenyl mono- or independently di-substituted with F, Cl, Br, (C
1
-C
3
)-alkoxyl or (C
1
-C
4
)-alkyl, exhibit a similar chemotactic index to that of amygdalin (natural product whose chemotaxis profile is similar to that of peptide T) and, consequently, are useful for treating inflammatory and/or allergic dermatophathies, such as psoriasis, and are especially much less toxic than amygdalin.